ACR Announces Request for Applications for Collaborative Research in Imaging Grant

The American College of Radiology® (ACR®) has released a request for applications for its Fund for Collaborative Research in Imaging (FCRI) Grant to power compelling, innovative research that advances radiology practice. The FCRI grant, available to ACR members, fuels pilot projects to test a new idea or support a new area or direction of clinical radiology research.

“The FCRI grant presents researchers with an opportunity to discover new paradigms in patient care,” said Pamela K. Woodard, MD, FACR, chair of the ACR Commission on Research. “Researchers are making new discoveries at a rapid pace and this grant plays an important role in fueling further innovation.”

Grants generally address a specific hypothesis and generate preliminary data that could be used to justify or strengthen subsequent comprehensive applications to national peer-reviewed funding agencies. The project must use ACR staff expertise or systems and outline a plan for future science and funding growth. Applicants must be ACR members.

“The FCRI grant is a launchpad for cutting-edge radiology research,” said Etta D. Pisano, MD, FACR, ACR chief research officer. “The potential for advances in radiology is boundless and I strongly urge clinical researchers to apply.”

More than one proposal may be funded but the total for all awards is limited to $400,000. Individuals or groups may submit applications with a total budget of up to $200,000.

Applicants must submit a complete application to Research@acr.org by 5pm ET, Jan. 13.

Visit the Fund for Collaborative Research in Imaging Grant site for more information and to start the application process.

Hot this week

Cartessa Aesthetics Partners with Classys to Bring EVERESSE to the U.S. Market

Classys, which is listed on the KOSDAQ, is one of South Korea's most distinguished aesthetic technology manufacturers, with devices distributed in 80+ markets globally. This partnership marks Classys's official entry into the American marketplace, with Cartessa Aesthetics as the exclusive distributor for EVERESSE, launched under the Volnewmer brand in current global markets.

Stryker Launches Next-Generation of SurgiCount+

Now integrated with Stryker's Triton technology, SurgiCount+ addresses two key challenges: retained surgical sponges and blood loss assessment. Integrating these previously separate digital solutions provides the added benefit of a more efficient, streamlined workflow for hospitals notes Stryker.

Nevro Receives CE Mark In Europe for It’s HFX iQ™ Spinal Cord Stimulation System

Nevro notes HFX iQ is the first and only SCS system with artificial intelligence (AI) technology that combines high-frequency (10 kHz) therapy built on landmark evidence that uses ongoing cloud data insights to deliver personalized pain relief

Recor Medical Reports: CMS Grants Distinct TPT Device Code and Category to Recor Medical for Ultrasound Renal Denervation

The approval of TPT offers incremental reimbursement payments for outpatient procedures performed with ultrasound renal denervation for Medicare fee-for-service beneficiaries. It becomes effective January 1, 2025, and is expected to remain effective for up to three years notes Recor Medical.

Jupiter Endovascular Reports | 1st U.S. Patient Treated with Jupiter Shape-shifting Thrombectomy Device

“Navigation challenges during endovascular procedures are often underappreciated and have led to under-adoption of life-saving procedures, such as pulmonary embolectomy. We have purpose-built our Endoportal Control technology to solve these issues and make important endovascular procedures accessible to more clinicians and their patients who can benefit from them,” said Carl J. St. Bernard, Jupiter Endovascular CEO. “This first case in the U.S. could not have gone better, and appears to validate the safety and performance we are seeing in our currently-enrolling European SPIRARE I study.”